|
|
|
|
Molecular Pharmacology, Vol 18, 136-143, Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics
1 Departments of Medicine and Biochemistry, McMaster University, Hamilton, Ontario, Canada L8N 3Z5
2 Department
of Medical Genetics, University of Toronto, Toronto, Ontario, Canada M5S 1A8
The structural basis for the cross-resistance and the common site of action of the benzoiosoquinoline alkaloids, (-)-emetine, (-)-tubulosine, (-)-cephaeline, and (-)-dehydroemetine, and of the phenanthroquinolizidine-type alkaloids, (-)-cryptopleurine, and the phenanthroindolizidine type, (-)-tylocrebrine, has been investigated by examining the cross-resistance of emetine-resistant mutants of Chinese hamster ovary cells to a large number of related compounds. On the basis of our results, we suggest that the aforementioned compounds possess common structural determinants which are responsible for their biological activity and that the requirement for biological activity is a planar molecule with two aromatic rings (rendered slightly electron richer, i.e., electronegative by methoxyl or hydroxyl groups) and the presence of a nucleophilic element such as nitrogen at a certain distance from the aromatic rings. The structure-activity relationship between the compounds indicates that the distance between the two aromatic rings, the angle between the nitrogen atom and the rings, and the electronegative character of the rings and planarity of the structure are critical features in determining the biological activity. Based on a comparison between the structures of compounds of the emetine type and those that are phenanthrene based, we have proposed the absolute sterochemistry of (-)-cryptopoeurine and (-)-tylocrebnne.
Note:
ACKNOWLEDGMENTS
The authors wish to thank Mr. David H. Chan for skillful technical
assistance and Dr. B. Bosnich ofthe Chemistry Department (University
of Toronto) for the circular dichroism measurements. We are also
grateful to various investigators for providing us with the compounds
employed here.
This article has been cited by other articles:
![]() |
N.-M. Chau, P. Rogers, W. Aherne, V. Carroll, I. Collins, E. McDonald, P. Workman, and M. Ashcroft Identification of Novel Small Molecule Inhibitors of Hypoxia-Inducible Factor-1 That Differentially Block Hypoxia-Inducible Factor-1 Activity and Hypoxia-Inducible Factor-1{alpha} Induction in Response to Hypoxic Stress and Growth Factors Cancer Res., June 1, 2005; 65(11): 4918 - 4928. [Abstract] [Full Text] [PDF] |
||||